MXPA02002186A - Mesoprogestinas (moduladores del receptor de progesterona) como un componente de los anticonceptivos femeninos. - Google Patents

Mesoprogestinas (moduladores del receptor de progesterona) como un componente de los anticonceptivos femeninos.

Info

Publication number
MXPA02002186A
MXPA02002186A MXPA02002186A MXPA02002186A MXPA02002186A MX PA02002186 A MXPA02002186 A MX PA02002186A MX PA02002186 A MXPA02002186 A MX PA02002186A MX PA02002186 A MXPA02002186 A MX PA02002186A MX PA02002186 A MXPA02002186 A MX PA02002186A
Authority
MX
Mexico
Prior art keywords
mesoprogestin
estrogen
use according
administration
pharmaceutical preparation
Prior art date
Application number
MXPA02002186A
Other languages
English (en)
Spanish (es)
Inventor
Kristof Chwalisz
Original Assignee
Jenapharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jenapharm Gmbh filed Critical Jenapharm Gmbh
Publication of MXPA02002186A publication Critical patent/MXPA02002186A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
MXPA02002186A 1999-08-31 2000-08-31 Mesoprogestinas (moduladores del receptor de progesterona) como un componente de los anticonceptivos femeninos. MXPA02002186A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38613399A 1999-08-31 1999-08-31
PCT/IB2000/002053 WO2001026603A2 (en) 1999-08-31 2000-08-31 Mesoprogestins (progesterone receptor modulators) as a component of female contraceptives

Publications (1)

Publication Number Publication Date
MXPA02002186A true MXPA02002186A (es) 2002-09-02

Family

ID=23524305

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02002186A MXPA02002186A (es) 1999-08-31 2000-08-31 Mesoprogestinas (moduladores del receptor de progesterona) como un componente de los anticonceptivos femeninos.

Country Status (28)

Country Link
EP (1) EP1605949A2 (ko)
JP (1) JP2003511399A (ko)
KR (1) KR20020038745A (ko)
CN (1) CN1384748A (ko)
AR (1) AR025455A1 (ko)
AU (1) AU781835B2 (ko)
BG (1) BG106441A (ko)
BR (1) BR0013711A (ko)
CA (1) CA2383650A1 (ko)
CO (1) CO5190694A1 (ko)
CZ (1) CZ2002707A3 (ko)
EA (1) EA006805B1 (ko)
EE (1) EE200200103A (ko)
HR (1) HRP20020265A2 (ko)
HU (1) HUP0202515A3 (ko)
IL (1) IL148415A0 (ko)
LT (1) LT5001B (ko)
LV (1) LV12940B (ko)
MX (1) MXPA02002186A (ko)
NO (1) NO20020998L (ko)
NZ (1) NZ517470A (ko)
PE (1) PE20010579A1 (ko)
PL (1) PL353994A1 (ko)
SI (1) SI20853A (ko)
SK (1) SK2982002A3 (ko)
UA (1) UA77150C2 (ko)
WO (1) WO2001026603A2 (ko)
YU (1) YU13902A (ko)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10236405A1 (de) 2002-08-02 2004-02-19 Schering Ag Progesteronrezeptormodulatoren mit erhöhter antigonadotroper Aktivität für die weibliche Fertilitätskontrolle und Hormonersatztherapie
DE50304970D1 (de) * 2002-08-02 2006-10-19 Schering Ag Progesteronrezeptormodulatoren mit erhöhter antigonadotroper aktivität für die weibliche fertilitätskontrolle und hormonersatztherapie
EP1624848A4 (en) * 2003-05-02 2009-02-25 Duramed Pharmaceuticals Inc METHOD FOR HORMONY TREATMENT WITH CONTRAZEPTVA SCHEMATES WITH EXTENDED CYCLE
US20050215535A1 (en) * 2004-03-24 2005-09-29 Kristof Chwalisz Sequential SPRM/progestin treatment
TW200603813A (en) * 2004-07-07 2006-02-01 Wyeth Corp Cyclic progestin regimens and kits
DE102005050729A1 (de) * 2005-10-19 2007-04-26 Schering Ag Verfahren zur präventiven bedarfsweisen hormonalen Kontrazeption
US9616073B2 (en) * 2009-04-14 2017-04-11 Laboratoire Hra-Pharma Method for on-demand contraception
CN110548034A (zh) * 2019-07-12 2019-12-10 广州莎蔓生物科技有限公司 一种怀孕阻断药物

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2054271A (en) 1932-05-17 1936-09-15 Schering Kahlbaum Ag Production of crystallized hormone esters
DE699310C (de) 1936-11-20 1940-11-27 Chemische Ind Ges Verfahren zur Herstellung von in 3-Stellung veresterten Verbindungen vom Typus des Oestradiols
US2225419A (en) 1937-03-01 1940-12-17 Schering Corp Process for the conversion of 17-cisalcohols of the cyclopentanopolyhydrophenanthrene series into the corresponding 17-trans-alcohols
US2611773A (en) 1951-08-21 1952-09-23 Upjohn Co Estradiol 17-cyclopenetanepropionate
US2990414A (en) 1957-03-26 1961-06-27 Syntex Sa 17-undecenoate of estradiol
DE3337450A1 (de) 1983-10-12 1985-04-25 Schering AG, 1000 Berlin und 4709 Bergkamen Prostaglandine und antigestagene fuer den schwangerschaftsabbruch
NZ226316A (en) * 1987-09-24 1991-10-25 Jencap Research Ltd Pharmaceutical contraceptive preparations and packages containing from 20-35 unit dosages comprising an estrogen and a progestin; the unit dosages having alternating estrogen and progestin dominance
US5439913A (en) 1992-05-12 1995-08-08 Schering Aktiengesellschaft Contraception method using competitive progesterone antagonists and novel compounds useful therein
US5516769A (en) 1993-02-19 1996-05-14 The Medical College Of Hampton Roads Method of inhibiting fertilization
DE4332283A1 (de) * 1993-09-20 1995-04-13 Jenapharm Gmbh Neue 11-Benzaldoximestradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE4332284C2 (de) * 1993-09-20 1997-05-28 Jenapharm Gmbh 11-Benzaldoxim-17beta-methoxy-17alpha-methoxymethyl-estradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE4429398C2 (de) 1994-08-09 1997-09-11 Jenapharm Gmbh Verwendung von Estra-1,3,5(10)-trien-Derivaten zur hormonalen Kontrazeption
DE4429397C2 (de) 1994-08-09 2003-11-20 Jenapharm Gmbh Estra-1,3,5(10)-trien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
EP0787002B1 (de) * 1994-10-24 2006-12-13 Schering Aktiengesellschaft Kompetitive progesteronantagonisten zur bedarfsorientierten weiblichen fertilitätskontrolle
US6040340A (en) * 1996-05-07 2000-03-21 Schering Aktiengesellschaft Implantation rates after in vitro fertilization, treatment of infertility and early pregnancy loss with a nitric oxide donor alone or in combination with progesterone, and a method for contraception with nitric oxide inhibitors
PL330916A1 (en) * 1996-06-25 1999-06-07 Akzo Nobel Nv Progestagen-antiprogestagen dosing schemes
WO1998005679A2 (en) * 1996-08-05 1998-02-12 Duke University Mixed agonists of the progesterone receptor and assays therefor
DE19809845A1 (de) * 1998-03-03 1999-09-09 Jenapharm Gmbh S-substituierte 11beta-Benzaldoxim-estra-4,9-dien-kohlensäurethiolester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen
CN1353717A (zh) * 1999-05-04 2002-06-12 莱加制药公司 四环黄体酮受体调节剂化合物及其方法

Also Published As

Publication number Publication date
BG106441A (bg) 2002-09-30
EP1605949A2 (en) 2005-12-21
HUP0202515A3 (en) 2004-06-28
AR025455A1 (es) 2002-11-27
CZ2002707A3 (cs) 2002-11-13
LV12940B (en) 2003-06-20
WO2001026603A3 (en) 2002-01-17
WO2001026603A2 (en) 2001-04-19
KR20020038745A (ko) 2002-05-23
SK2982002A3 (en) 2002-07-02
SI20853A (sl) 2002-10-31
LT2002035A (lt) 2002-10-25
AU3215001A (en) 2001-04-23
PE20010579A1 (es) 2001-06-04
CA2383650A1 (en) 2001-04-19
YU13902A (sh) 2006-01-16
IL148415A0 (en) 2002-09-12
AU781835B2 (en) 2005-06-16
NO20020998D0 (no) 2002-02-28
EE200200103A (et) 2003-04-15
HRP20020265A2 (en) 2004-02-29
NO20020998L (no) 2002-03-14
LT5001B (lt) 2003-03-25
JP2003511399A (ja) 2003-03-25
PL353994A1 (en) 2003-12-15
BR0013711A (pt) 2002-05-07
HUP0202515A2 (hu) 2002-12-28
UA77150C2 (en) 2006-11-15
CN1384748A (zh) 2002-12-11
EA006805B1 (ru) 2006-04-28
CO5190694A1 (es) 2002-08-29
EA200200284A1 (ru) 2002-10-31
NZ517470A (en) 2004-03-26

Similar Documents

Publication Publication Date Title
US6506390B2 (en) Progestogen-anti-progestogen regimens
AU707235B2 (en) Competitive progesterone antagonists for demand-oriented female birth control
US20050064031A1 (en) Combination contraceptive, kits that contain the latter, and a method that uses the latter
AU781835B2 (en) Mesoprogestins (progesterone receptor modulators) as a component of female contraceptives
EP1605924B1 (en) Mesoprogestins (progesterone receptor modulators) as a component of compositions for hormone replacement therapy (hrt)
US7629334B1 (en) Mesoprogrestins (progesterone receptor modulations) as a component of compositions for hormone replacement therapy (HRT)
ZA200201614B (en) Mesoprogestins (progesterone receptor modulators) as a component of female contraceptives.

Legal Events

Date Code Title Description
GB Transfer or rights
FA Abandonment or withdrawal